Charles River reports Q4 EPS $2.98, consensus $2.75

Reports Q4 revenue $1.1B, consensus $1.04B. James Foster, chairman, president and CEO, said, "We are pleased with the outstanding finish to the year. We exceeded our expectations due primarily to another robust performance in the DSA segment, and quarterly revenue exceeded $1 billion for the first time. We believe our 2022 performance demonstrates the strength of our business – including our leading market position, unique non-clinical focus, and the resilience of our large, diversified client base – as we meet the sustained pace of client demand despite the macroeconomic environment."